Literature DB >> 13784058

Vaccination against tuberculosis with nonliving vaccines. 3. Vaccination of guinea pigs with fractions of phenol-killed tubercle bacilli.

D W WEISS, A Q WELLS.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS/immunology

Mesh:

Substances:

Year:  1960        PMID: 13784058     DOI: 10.1164/arrd.1960.82.3.339

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  11 in total

1.  Enhancement of avian sarcoma virus-induced tumor growth after pretreatment with BCG.

Authors:  M A Wainberg; E Israel
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

2.  Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Relationship of antigen dose to heightened primary and secondary immune responses to sheep red blood cells.

Authors:  D J Yashphe
Journal:  Clin Exp Immunol       Date:  1972-12       Impact factor: 4.330

3.  Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). I. Primary and secondary responses to sheep red blood cells and T2 phage.

Authors:  D J Yashphe; D W Weiss
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

4.  Comparison of in vitro effects of anti-skin serum with anti lymphocyte serum.

Authors:  M Cohen; D Nelken
Journal:  Clin Exp Immunol       Date:  1973-03       Impact factor: 4.330

5.  Studies on the mode of action of the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG).

Authors:  C B Steinkuller; L G Krigbaum; D W Weiss
Journal:  Immunology       Date:  1969-02       Impact factor: 7.397

6.  INDUCTION OF ACQUIRED RESISTANCE IN GUINEA PIGS WITH DEFATTED MYCOBACTERIUM TUBERCULOSIS VACCINES.

Authors:  D W SMITH; G B FREGNAN; L DELAQUERRIERE; E VALDIVIA
Journal:  J Bacteriol       Date:  1964-07       Impact factor: 3.490

7.  Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.

Authors:  M A Wainberg; V Deutsch; D W Weiss
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

8.  BCG treatment of malignant pleural effusions in the rat.

Authors:  M V Pimm; D G Hopper; R W Baldwin
Journal:  Br J Cancer       Date:  1976-10       Impact factor: 7.640

9.  STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION.

Authors:  D W WEISS; R S BONHAG; J A PARKS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

10.  Studies on the heterologous immunogenicity of a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). II. Protection against tumor isografts.

Authors:  D W Weiss; R S Bonhag; P Leslie
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.